{"transactions":[{"id":710779,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-13T20:06:15.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7040,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."}],"balance_after":0,"derivative":{"exercise_price":0.87,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":7040},"source":{"system":"sec-edgar","filing":"0001628280-26-048014","document":"wk-form4_1783973172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000162828026048014/wk-form4_1783973172.xml","form_type":"4"}},{"id":710778,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-13T20:06:15.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each stock option having a per share exercise price that was less than the per share cash consideration (each, an \"in-the-money option\") was canceled and converted into the right to receive, for each share of Common Stock issuable upon the exercise of such in-the-money option immediately prior to the Effective Time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the excess of the per share cash consideration over the per share exercise price of such in-the-money option plus (b) one CVR."}],"balance_after":0,"derivative":{"exercise_price":1.41,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001628280-26-048014","document":"wk-form4_1783973172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000162828026048014/wk-form4_1783973172.xml","form_type":"4"}},{"id":710777,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:06:15.000Z","date":"2026-07-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":85153,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated May 1, 2026, by and among the Issuer, Essence Parent Inc., a Delaware corporation (\"Parent\") and Essence MergerCo Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"MergerCo\"), pursuant to which, on July 13, 2026 (the \"Effective Time\"), MergerCo merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the Effective Time, each share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") was converted into the right to receive (a) an amount in cash equal to $3.16 per share, without interest (the \"per share cash consideration\"), and (b) one contractual contingent value right per share (each, a \"CVR\" and, together with the per share cash consideration, the \"merger consideration\"), representing the right to participate in contingent payments in cash, without interest, upon the achievement of certain milestones, subject to any applicable withholding taxes. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 79,873 restricted stock units (each, a \"RSU\"). At the Effective Time, each RSU with respect to Common Stock outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested), and was canceled and converted into the right to receive, with respect to each share of Common Stock subject to such RSU immediately prior to the effective time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the per share cash consideration, plus (b) one CVR, subject to certain exceptions."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\") was converted into the right to receive (a) an amount in cash equal to $3.16 per share, without interest (the \"per share cash consideration\"), and (b) one contractual contingent value right per share (each, a \"CVR\" and, together with the per share cash consideration, the \"merger consideration\"), representing the right to participate in contingent payments in cash, without interest, upon the achievement of certain milestones, subject to any applicable withholding taxes. From and after the Effective Time, all such shares of Common Stock were no longer outstanding and were automatically canceled."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 79,873 restricted stock units (each, a \"RSU\"). At the Effective Time, each RSU with respect to Common Stock outstanding immediately prior to the Effective Time vested in full (to the extent then-unvested), and was canceled and converted into the right to receive, with respect to each share of Common Stock subject to such RSU immediately prior to the effective time, (a) a cash payment (rounded down to the nearest cent), without interest and subject to applicable tax withholding and deductions, equal to the per share cash consideration, plus (b) one CVR, subject to certain exceptions."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-26-048014","document":"wk-form4_1783973172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000162828026048014/wk-form4_1783973172.xml","form_type":"4"}},{"id":729442,"issuer":{"id":7875,"kind":"organization","name":"FibroBiologics, Inc.","symbol":"FBLG"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T00:02:13.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":30803,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting."}],"balance_after":30803,"derivative":{"exercise_price":0.7503,"expiration_date":"2036-06-22","underlying":"Common Stock","underlying_shares":30803},"source":{"system":"sec-edgar","filing":"0001493152-26-029851","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000149315226029851/ownership.xml","form_type":"4"}},{"id":757513,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-01T20:23:36.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":79873,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) May 28, 2027 and (ii) the Issuer's next annual meeting of stockholders following May 28, 2026."}],"balance_after":85153,"source":{"system":"sec-edgar","filing":"0001628280-26-039525","document":"wk-form4_1780345413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000162828026039525/wk-form4_1780345413.xml","form_type":"4"}},{"id":830414,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2026-03-24T21:22:09.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":4874691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the \"2012 Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1,218,672 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030."}],"balance_after":4874691,"derivative":{"exercise_price":0.28,"expiration_date":"2036-03-20","underlying":"Common Stock","underlying_shares":4874691},"source":{"system":"sec-edgar","filing":"0001104659-26-033958","document":"tm269618-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465926033958/tm269618-4_4seq1.xml","form_type":"4"}},{"id":901608,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2026-02-17T21:09:41.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":156240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents an annual option grant under the TuHURA Biosciences, Inc. 2024 Equity Incentive Plan. One-third of the stock options become exercisable on the first, second, and third anniversaries of February 12, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual option grant under the TuHURA Biosciences, Inc. 2024 Equity Incentive Plan. One-third of the stock options become exercisable on the first, second, and third anniversaries of February 12, 2026."}],"balance_after":156240,"derivative":{"exercise_price":1.29,"expiration_date":"2036-02-12","underlying":"Common Stock","underlying_shares":156240},"source":{"system":"sec-edgar","filing":"0000897069-26-000360","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000089706926000360/form4.xml","form_type":"4"}},{"id":1113869,"issuer":{"id":7875,"kind":"organization","name":"FibroBiologics, Inc.","symbol":"FBLG"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T23:23:52.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting."}],"balance_after":22000,"derivative":{"exercise_price":0.8725,"expiration_date":"2025-06-11","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001641172-25-014934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000164117225014934/ownership.xml","form_type":"4"}},{"id":1127996,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-02T20:09:32.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":7040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest in full on the earlier of (i) May 29, 2026 and (ii) the Issuer's next annual meeting of stockholders following May 29, 2025."}],"balance_after":7040,"derivative":{"exercise_price":0.87,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":7040},"source":{"system":"sec-edgar","filing":"0001628280-25-028828","document":"wk-form4_1748894965.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000162828025028828/wk-form4_1748894965.xml","form_type":"4"}},{"id":1127995,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T20:09:32.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":5280,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards vest in full on the earlier of (i) May 29, 2026 and (ii) the Issuer's next annual meeting of stockholders following May 29, 2025."}],"balance_after":5280,"source":{"system":"sec-edgar","filing":"0001628280-25-028828","document":"wk-form4_1748894965.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000162828025028828/wk-form4_1748894965.xml","form_type":"4"}},{"id":1138433,"issuer":{"id":5856,"kind":"organization","name":"CytoDyn Inc."},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Non-qualified stock option (right to buy)","published_at":"2025-05-23T00:31:53.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was approved by the Company's Compensation Committee effective May 15, 2025, pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the \"Plan\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"250,000 shares will vest on May 15, 2026, and the balance will vest in equal monthly installments at the conclusion of each month of Continuous Service (as the term is defined in the Plan ) from May 2026 through April 2029."}],"balance_after":1000000,"derivative":{"exercise_price":0.41,"expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001104659-25-052122","document":"tm2515909-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1175680/000110465925052122/tm2515909-2_4seq1.xml","form_type":"4"}},{"id":1184180,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T20:19:14.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards vest over a three (3) year period in equal annual installments the first of which will be April 1, 2026."}],"balance_after":40000,"derivative":{"exercise_price":1.41,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001628280-25-016196","document":"wk-form4_1743625147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000162828025016196/wk-form4_1743625147.xml","form_type":"4"}},{"id":1311370,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true}}],"security":"Options (Right to Buy)","published_at":"2025-01-06T22:08:15.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":51275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents an annual option grant under the TuHURA Biosciences, Inc. Non-Employee Director Compensation Program.  One-third of the stock options become exercisable on the first, second, and third anniversaries of January 2, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an annual option grant under the TuHURA Biosciences, Inc. Non-Employee Director Compensation Program.  One-third of the stock options become exercisable on the first, second, and third anniversaries of January 2, 2025."}],"balance_after":51275,"derivative":{"exercise_price":4.11,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":51275},"source":{"system":"sec-edgar","filing":"0000897069-25-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000089706925000037/form4.xml","form_type":"4"}},{"id":1422211,"issuer":{"id":7875,"kind":"organization","name":"FibroBiologics, Inc.","symbol":"FBLG"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-27T23:53:13.000Z","date":"2024-08-27","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting."}],"balance_after":5000,"derivative":{"exercise_price":1.73,"expiration_date":"2034-08-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001493152-24-034068","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000149315224034068/ownership.xml","form_type":"4"}},{"id":1791079,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO and Interim CFO"}}],"security":"Options (Right to Buy)","published_at":"2023-09-01T22:00:35.000Z","date":"2023-08-30","kind":"grant","planned":false,"acquired":true,"shares":23142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 25% of the options vest on August 30, 2024, with the remaining shares vesting in 36 equal monthly installments commencing on September 30, 2024."}],"balance_after":23142,"derivative":{"exercise_price":4.655,"expiration_date":"2033-08-30","underlying":"Common Stock","underlying_shares":23142},"source":{"system":"sec-edgar","filing":"0001493152-23-031537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000149315223031537/ownership.xml","form_type":"4"}},{"id":1870435,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO, and CFO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-06-02T20:05:29.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":59800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 59,800 restricted stock units, which will be settled in shares of the Issuer's common stock. The restricted stock units vest in full on June 1, 2024."}],"balance_after":68902,"source":{"system":"sec-edgar","filing":"0001493152-23-019950","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000149315223019950/ownership.xml","form_type":"4"}},{"id":2196093,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option (right to buy)","published_at":"2022-08-03T20:30:30.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":1200634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% on August 1, 2023 with the remainder to vest in 36 equal monthly installments thereafter."}],"balance_after":1200634,"derivative":{"exercise_price":0.1757,"expiration_date":"2022-08-02","underlying":"Common Stock","underlying_shares":1200634},"source":{"system":"sec-edgar","filing":"0001493152-22-021170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000149315222021170/ownership.xml","form_type":"4"}},{"id":2196092,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-08-03T20:30:30.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":400145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 400,145 restricted stock units, which will be settled in shares of the Issuer's common stock. The restricted stock units vest in 4 equal annual installments beginning on August 1, 2023."}],"balance_after":455145,"source":{"system":"sec-edgar","filing":"0001493152-22-021170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000149315222021170/ownership.xml","form_type":"4"}},{"id":2388958,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"Hoffman Robert E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-17T21:00:46.000Z","date":"2022-02-15","kind":"purchase","acquired":true,"shares":55000,"price":0.469,"value":25795.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4625 to $0.4697 per share, inclusive. The reporting person undertakes to provide to Kintara Therapeutics, Inc., any security holder of Kintara Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein."}],"balance_after":55000,"source":{"system":"sec-edgar","filing":"0000905718-22-000393","document":"kintara_fm4feb152022.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000090571822000393/kintara_fm4feb152022.xml","form_type":"4"}},{"id":2518136,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options (Right to Buy)","published_at":"2021-11-10T21:18:07.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":3519170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to the reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to the reporting person's continued employment, the shares subject to the option shall vest as follows: 25% of the shares subject to the option shall vest on November 8, 2022, and the remainder shall vest in equal monthly installments over the following thirty-six (36) months."}],"balance_after":3519170,"derivative":{"exercise_price":0.96,"expiration_date":"2031-11-08","underlying":"Common Stock","underlying_shares":3519170},"source":{"system":"sec-edgar","filing":"0000899243-21-043913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000089924321043913/doc4.xml","form_type":"4"}},{"id":2562257,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2021-09-23T00:35:13.000Z","date":"2021-09-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 22, 2021."}],"balance_after":100000,"derivative":{"exercise_price":1.24,"expiration_date":"2031-09-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000905718-21-001221","document":"kintara_fm4sep222021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000090571821001221/kintara_fm4sep222021.xml","form_type":"4"}},{"id":2657630,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2021-06-23T21:14:28.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":21.54,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-21-042777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000120919121042777/doc4.xml","form_type":"4"}},{"id":3028817,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2020-09-18T01:05:16.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued service, the options vest in 12 equal monthly installments commencing on October 15, 2020"}],"balance_after":120000,"derivative":{"exercise_price":1.7,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000905718-20-000967","document":"kintara_fm4sep152020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000090571820000967/kintara_fm4sep152020.xml","form_type":"4"}},{"id":3096805,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2020-06-30T20:11:13.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On September 5, 2019, the reporting person received options to purchase 39,567 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":75000,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0001213900-20-016308","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390020016308/ownership.xml","form_type":"4"}},{"id":3099152,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2020-06-26T20:06:26.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":23000,"derivative":{"exercise_price":17.97,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-20-039067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000120919120039067/doc4.xml","form_type":"4"}},{"id":3333111,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-23T21:28:00.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":100000,"derivative":{"exercise_price":25.02,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-061794","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919119061794/doc4.xml","form_type":"4"}},{"id":3415063,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-09-13T20:25:48.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest pro rata on a monthly basis commencing on October 12, 2019 for the next 12 months with full vesting, if not fully vested at such time, on the date of the Aravive Inc.'s next annual meeting of stockholders."}],"balance_after":7500,"derivative":{"exercise_price":5.77,"exercise_date":"2019-10-12","expiration_date":"2029-09-11","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-19-023563","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000089924319023563/doc4.xml","form_type":"4"}},{"id":3419673,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:46:12.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":35433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":35433,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":35433},"source":{"system":"sec-edgar","filing":"0000905718-19-000767","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000090571819000767/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3419672,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:46:12.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":39567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, the shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019."}],"balance_after":39567,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":39567},"source":{"system":"sec-edgar","filing":"0000905718-19-000767","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000090571819000767/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3477285,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2019-06-27T20:05:05.000Z","date":"2019-06-25","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":13000,"derivative":{"exercise_price":19.55,"expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-19-039240","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000120919119039240/doc4.xml","form_type":"4"}},{"id":3544609,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2019-05-01T22:32:00.000Z","date":"2019-04-30","kind":"disposition_to_issuer","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance stock unit represents the right to receive one share of common stock, to vest upon achievement of specified targets related to the Company's financial performance. Such performance stock units were unvested."}],"balance_after":0,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-19-007626","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390019007626/ownership.xml","form_type":"4"}},{"id":3702132,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-01-08T02:24:49.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person is amending the Form 4 originally filed to report the correct exercise price, which is $3.61. The exercise price was incorrectly reported in the initial Form 4 due to a typographical error."},{"field":"shares","element":"transactionShares","label":"F3","text":"These options vest as follows: (i) 1,563 shares of common stock vest immediately upon grant and (ii) 625 will vest on a monthly basis over the next five months commencing on February 3, 2019 with full vesting, if not fully vested at such time, on the date of the Aravive Inc.'s next annual meeting of stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vest as follows: (i) 1,563 shares of common stock vest immediately upon grant and (ii) 625 will vest on a monthly basis over the next five months commencing on February 3, 2019 with full vesting, if not fully vested at such time, on the date of the Aravive Inc.'s next annual meeting of stockholders."}],"balance_after":4688,"derivative":{"exercise_price":3.61,"exercise_date":"2019-01-03","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001213900-19-000327","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390019000327/ownership.xml","form_type":"4/A","original_submission_date":"2019-01-07"}},{"id":3702131,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-01-08T02:24:49.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The reporting person is amending the Form 4 originally filed to report the correct exercise price, which is $3.61. The exercise price was incorrectly reported in the initial Form 4 due to a typographical error."},{"field":"shares","element":"transactionShares","label":"F2","text":"These options vest as follows: (i) 625 shares of common stock vest immediately upon grant and (ii) the balance will vest pro rata on a monthly basis over the next 33 months commencing on February 12, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest as follows: (i) 625 shares of common stock vest immediately upon grant and (ii) the balance will vest pro rata on a monthly basis over the next 33 months commencing on February 12, 2019."}],"balance_after":7500,"derivative":{"exercise_price":3.61,"exercise_date":"2019-01-03","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-19-000327","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390019000327/ownership.xml","form_type":"4/A","original_submission_date":"2019-01-07"}},{"id":3702130,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-01-07T19:09:41.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These options vest as follows: (i) 1,563 shares of common stock vest immediately upon grant and (ii) 625 will vest on a monthly basis over the next five months commencing on February 3, 2019 with full vesting, if not fully vested at such time, on the date of the Aravive Inc.'s next annual meeting of stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest as follows: (i) 1,563 shares of common stock vest immediately upon grant and (ii) 625 will vest on a monthly basis over the next five months commencing on February 3, 2019 with full vesting, if not fully vested at such time, on the date of the Aravive Inc.'s next annual meeting of stockholders."}],"balance_after":4688,"derivative":{"exercise_price":3.69,"exercise_date":"2019-01-03","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001213900-19-000277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390019000277/ownership.xml","form_type":"4"}},{"id":3702129,"issuer":{"id":114535,"kind":"organization","name":"Aravive, Inc.","symbol":"ARAV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-01-07T19:09:41.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options vest as follows: (i) 625 shares of common stock vest immediately upon grant and (ii) the balance will vest pro rata on a monthly basis over the next 33 months commencing on February 12, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest as follows: (i) 625 shares of common stock vest immediately upon grant and (ii) the balance will vest pro rata on a monthly basis over the next 33 months commencing on February 12, 2019."}],"balance_after":7500,"derivative":{"exercise_price":3.69,"exercise_date":"2019-01-03","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-19-000277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390019000277/ownership.xml","form_type":"4"}},{"id":3728048,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-19T01:07:33.000Z","date":"2018-12-15","kind":"grant","acquired":true,"shares":71000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":71000,"derivative":{"exercise_price":24.97,"expiration_date":"2028-12-15","underlying":"Common Stock","underlying_shares":71000},"source":{"system":"sec-edgar","filing":"0001209191-18-063349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118063349/doc4.xml","form_type":"4"}},{"id":3767800,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2018-11-13T21:37:36.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in twelve (12) equal monthly installments beginning on December 8, 2018."}],"balance_after":40000,"derivative":{"exercise_price":0.6099,"expiration_date":"2028-11-08","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001213900-18-015511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390018015511/ownership.xml","form_type":"4"}},{"id":3877232,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-07-04T01:03:22.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 30, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options vest and become exercisable with respect to 32,500 shares on the first anniversary of his first day of employment (the \"Grant Date\"), followed by 97,500 shares vesting ratably each month over the subsequent three years, such that 130,000 options will be fully vested on the four year anniversary of the Grant Date."}],"balance_after":100000,"derivative":{"exercise_price":15.3,"expiration_date":"2027-04-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-041385","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041385/doc4.xml","form_type":"4"}},{"id":3877231,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Common Stock","published_at":"2018-07-04T01:03:22.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":1060,"price":38.7953,"value":41123.018,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 30, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The range of sales prices received was $38.625 to $38.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":1280,"source":{"system":"sec-edgar","filing":"0001209191-18-041385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041385/doc4.xml","form_type":"4"}},{"id":3877230,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Common Stock","published_at":"2018-07-04T01:03:22.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":28940,"price":38.1516,"value":1104107.304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 30, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The range of sales prices received was $37.60 to $38.60. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price."}],"balance_after":2340,"source":{"system":"sec-edgar","filing":"0001209191-18-041385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041385/doc4.xml","form_type":"4"}},{"id":3877229,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Common Stock","published_at":"2018-07-04T01:03:22.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":30000,"price":15.3,"value":459000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of May 30, 2018."}],"balance_after":31280,"source":{"system":"sec-edgar","filing":"0001209191-18-041385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041385/doc4.xml","form_type":"4"}},{"id":3877228,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Common Stock","published_at":"2018-07-04T01:03:22.000Z","date":"2018-04-30","kind":"other","acquired":true,"shares":744,"price":13.2175,"value":9833.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2018."}],"balance_after":1280,"source":{"system":"sec-edgar","filing":"0001209191-18-041385","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919118041385/doc4.xml","form_type":"4"}},{"id":3900216,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2018-06-08T20:09:03.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":13000,"derivative":{"exercise_price":16.35,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001209191-18-036658","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000120919118036658/doc4.xml","form_type":"4"}},{"id":3962346,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2018-04-17T20:15:31.000Z","date":"2018-04-13","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the Company's financial performance."}],"balance_after":200000,"derivative":{"expiration_date":"2022-07-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-18-004593","document":"f4041318hoffman_delmar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390018004593/f4041318hoffman_delmar.xml","form_type":"4"}},{"id":3962345,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2018-04-17T20:15:31.000Z","date":"2018-04-13","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"12,000 options vest on March 31, 2019, and 3,000 options vest each three months thereafter starting June 30, 2019."}],"balance_after":36000,"derivative":{"exercise_price":1.06,"exercise_date":"2021-03-31","expiration_date":"2028-04-13","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001213900-18-004593","document":"f4041318hoffman_delmar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000121390018004593/f4041318hoffman_delmar.xml","form_type":"4"}},{"id":4125513,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-20T21:13:41.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":56667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant."}],"balance_after":56667,"derivative":{"exercise_price":17,"expiration_date":"2027-12-18","underlying":"Common Stock","underlying_shares":56667},"source":{"system":"sec-edgar","filing":"0001209191-17-066625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919117066625/doc4.xml","form_type":"4"}},{"id":4125512,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Common Stock","published_at":"2017-12-20T21:13:41.000Z","date":"2017-10-31","kind":"other","acquired":true,"shares":536,"price":13.0475,"value":6993.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 31, 2017."}],"balance_after":536,"source":{"system":"sec-edgar","filing":"0001209191-17-066625","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919117066625/doc4.xml","form_type":"4"}},{"id":4160728,"issuer":{"id":171845,"kind":"organization","name":"CombiMatrix Corp","symbol":"CBMX"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2017-11-16T22:53:38.000Z","date":"2017-11-14","kind":"other","acquired":true,"shares":1619,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This warrant was assumed by Invitae in the merger and replaced with a warrant to purchase 1,407 shares of Invitae common stock for $53.84 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Disposed of pursuant to merger agreement between issuer and Invitae Corporation in exchange for 5,752 shares of Invitae common stock having a market value of $7.86 per share on the effective date of the merger."}],"balance_after":0,"derivative":{"exercise_price":46.8,"expiration_date":"2018-12-20","underlying":"Common Stock","underlying_shares":1619},"source":{"system":"sec-edgar","filing":"0001179110-17-014225","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000117911017014225/edgar.xml","form_type":"4"}},{"id":4160727,"issuer":{"id":171845,"kind":"organization","name":"CombiMatrix Corp","symbol":"CBMX"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-16T22:53:38.000Z","date":"2017-11-14","kind":"other","acquired":false,"shares":6618,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of pursuant to merger agreement between issuer and Invitae Corporation in exchange for 5,752 shares of Invitae common stock having a market value of $7.86 per share on the effective date of the merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-17-014225","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000117911017014225/edgar.xml","form_type":"4"}},{"id":4160726,"issuer":{"id":171845,"kind":"organization","name":"CombiMatrix Corp","symbol":"CBMX"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-16T22:53:38.000Z","date":"2017-11-14","kind":"disposition_to_issuer","acquired":false,"shares":2001,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock of the issuer underlying restricted stock units that were cancelled in the merger pursuant to merger agreement between issuer and Invitae Corporation in exchange for 1,737 shares of Invitae common stock having a market value of $7.86 per share on the effective date of the merger."}],"balance_after":6618,"source":{"system":"sec-edgar","filing":"0001179110-17-014225","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000117911017014225/edgar.xml","form_type":"4"}},{"id":4285815,"issuer":{"id":4871,"kind":"organization","name":"Kura Oncology, Inc.","symbol":"KURA"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2017-06-12T21:48:59.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests in full on the one year anniversary of the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":8.6,"expiration_date":"2027-06-08","underlying":"Common stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-039256","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000120919117039256/doc4.xml","form_type":"4"}},{"id":4308563,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-05-23T20:09:54.000Z","date":"2017-05-19","kind":"grant","acquired":true,"shares":50000,"price":1.8,"value":90000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable and was issued pursuant to conditions of the Letter Agreement, dated May 15, 2017, by and between the Company and the lead investor in connection with the Company's public offering completed on May 19, 2017, and filed with the Securities and Exchange Commission on May 22, 2017 as Exhibit A of Exhibit 10.2 of the Company's Quarterly Report on Form 10-Q."}],"balance_after":50000,"derivative":{"exercise_price":1.8,"expiration_date":"2027-05-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-17-000843","document":"form4-05232017_050543.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000843/form4-05232017_050543.xml","form_type":"4"}},{"id":4347037,"issuer":{"id":7133,"kind":"organization","name":"HERON THERAPEUTICS, INC. /DE/"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & SVP, Finance"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-04-25T00:54:39.000Z","date":"2017-04-24","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable with respect to 32,500 shares on the first anniversary of his first day of employment (the \"Grant\nDate\"), followed by 97,500 shares vesting ratably each month over the subsequent three years, such that 130,000 options will be fully\nvested on the four year anniversary of the Grant Date."}],"balance_after":130000,"derivative":{"exercise_price":15.3,"expiration_date":"2027-04-24","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001209191-17-028037","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/818033/000120919117028037/doc4.xml","form_type":"4"}},{"id":4361996,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-04-04T19:23:14.000Z","date":"2017-04-02","kind":"exercise","acquired":false,"shares":1543,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit is the economic equivalent of one share of common stock of the Issuer"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vest over 3 years from April 2, 2015, 1/3 on each anniversary of the date of grant, subject to the Reporting Person's continued employment or service with the Issuer on each such vesting date."}],"balance_after":1543,"derivative":{"underlying":"Common Stock","underlying_shares":1543},"source":{"system":"sec-edgar","filing":"0001415889-17-000594","document":"form4-04042017_040405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000594/form4-04042017_040405.xml","form_type":"4"}},{"id":4361995,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T19:23:14.000Z","date":"2017-04-02","kind":"exercise","acquired":true,"shares":1543,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents conversion of restricted stock units into common stock upon vesting of 1/3 of such units granted on April 2, 2015."}],"balance_after":4438,"source":{"system":"sec-edgar","filing":"0001415889-17-000594","document":"form4-04042017_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000594/form4-04042017_040405.xml","form_type":"4"}},{"id":4508165,"issuer":{"id":167746,"kind":"organization","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","symbol":"MBVX"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2017-01-03T20:57:38.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":4100,"price":3.38,"value":13858.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such Options shall vest in equal annual installments over a three year period."}],"balance_after":4100,"derivative":{"exercise_price":3.38,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001415889-17-000022","document":"form4-01032017_050126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109196/000141588917000022/form4-01032017_050126.xml","form_type":"4"}},{"id":4547196,"issuer":{"id":151567,"kind":"organization","name":"INNOVUS PHARMACEUTICALS, INC.","symbol":"INNV"},"owners":[{"id":30860,"kind":"person","name":"Hoffman Robert E.","position":1,"cik":"0001166288","reported_name":"HOFFMAN ROBERT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Restricted Stock units","published_at":"2016-11-21T11:00:29.000Z","date":"2016-09-06","kind":"grant","acquired":true,"shares":2500000,"price":0.27,"value":675000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Reporting Person was granted a Restricted Stock Unit on September 6, 2016 of       2,500,000 shares, which shall vest according to the following schedule:  1/3 after one year of employment with the Issuer and then in equal quarterly increments over the next eight quarters upon continuous employment with the Company."},{"field":"kind","element":"transactionCoding","label":"F3","text":"These restricted stock units were granted pursuant to the Issuer's 2016 Equity Incentive Plan."}],"balance_after":2500000,"derivative":{"exercise_date":"2016-11-16","expiration_date":"2026-11-16","underlying":"Common Stock","underlying_shares":2500000},"source":{"system":"sec-edgar","filing":"0001415889-16-007484","document":"form4-11212016_061118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1166288/000141588916007484/form4-11212016_061118.xml","form_type":"4"}}]}